🔗 Permalink

Inventor profile of:

Christopher H. Contag

City:

Stanford, California

Country:

United States

Published Applications:

Last publication date:

2019-08-01

Top Assignees for applications by Christopher H. Contag

The entities that hold a legal rights for patent applications filed by inventor Contag Christopher H.:

The Board of Trustees of the Leland Stanford Junior University 3 Stanford, CA United States
The Board of Trustees of the Leland Stanford Junior University 2 Palo Alto, CA United States
National Institute of Health (NIH) 1 Bethesda, MD United States
The Trustees of the Leland Stanford Junior University 1 Stanford, CA United States

Recent patent applications by Contag Christopher H.

Christopher H. Contag from Stanford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-08-01

US20190231818A1

Human necessities

IMMUNE EFFECTOR CELLS PRE-INFECTED WITH ONCOLYTIC VIRUS

#2 | 2015-11-12

US20150320800A1

Human necessities

Immune effector cells pre-infected with oncolytic virus

#3 | 2014-01-09

US20140010791A1

Human necessities

Methods for regulating protein function in cells in vivo using synthetic small molecules

#4 | 2013-01-31

US20130028875A1

Human necessities

Immune effector cells pre-infected with oncolytic virus

#5 | 2012-01-26

US20120021923A1

Human necessities

METHODS AND SYSTEMS TO DIAGNOSE A CONDITION IN AN INDIVIDUAL

#6 | 2011-11-10

US20110275524A1

Chemistry; metallurgy

METHODS AND SYSTEMS TO DETECT AN ACTIVE PROTEASE IN A SAMPLE

#7 | 2011-06-30

US20110160146A1

Human necessities

Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance

#8 | 2010-02-11

US20100034777A1

Human necessities

Method for regulating protein function in cells in vivo using synthetic small molecules

#9 | 2009-12-17

US20090312402A1

Human necessities

ENCAPSULATED NANOPARTICLES FOR DRUG DELIVERY

#10 | 2008-04-24

US20080095856A1

Human necessities

Encapsulated Nanoparticles for Drug Delivery

#11 | 2007-11-01

US20070254852A1

Chemistry; metallurgy

Nitroreductase enzymes

#12 | 2007-04-05

US20070077231A1

Human necessities

Immune effector cells pre-infected with oncolytic virus

InventorID:

65787 ⎘